Complete Filing Data
REGENEREX PHARMA, INC. reported Net Income Loss of -$2.53 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean REGENEREX PHARMA, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.5M | -$3.5M | -$137.3K | -$195.6K | -$353.8K | $111.6K | -$93.6K | -$49.7K | -$2.6K | $859.8K | -$995.5K | -$659.7K | -$212.1K | -$27.4K | -$6.4K |
| Cost of Revenue * | $246.7K | $1.7K | |||||||||||||
| General And Administrative Expense | $1.2M | $1.1M | $96.2K | $126.3K | $43.4K | $61.0K | $91.7K | $49.5K | $2.6K | $25.0K | $30.4K | ||||
| Interest Expense | $320.0K | $80.6K | $66.8K | $59.1K | $42.9K | $28.7K | $778.00 | $3.6K | $4.4K | -$3.3K | |||||
| Operating Income Loss | -$1.8M | -$3.5M | -$96.2K | -$126.3K | -$43.4K | -$77.0K | -$91.7K | -$49.5K | -$2.6K | ||||||
| Operating Expenses | $1.8M | $3.5M | $96.2K | $126.3K | $43.4K | $77.9K | $91.7K | $49.5K | $2.6K | ||||||
| Nonoperating Income Expense | -$700.9K | -$78.0K | -$41.2K | -$63.8K | -$47.5K | -$34.6K | -$1.8K | ||||||||
| Income Loss From Continuing Operations Per Basic And Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | -$0.01 | |||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.01 | -$0.01 | $0.00 | $0.00 | |||||||||||
| Selling And Marketing Expense | $8.8K | $16.9K | |||||||||||||
| Revenues | $1.8K | $2.6K | |||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share | |||||||||||||||
| Gross Profit | -$244.9K | $896.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q1 2016 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$814.0K | -$663.6K | -$314.5K | -$529.6K | -$272.6K | -$264.0K | -$2.8M | -$185.6K | -$49.4K | -$18.4K | -$23.2K | -$79.4K | -$33.8K | -$34.0K | -$33.7K | -$25.8K | -$9.8K | -$20.6K | -$18.5K | -$32.3K | -$53.7K | -$4.8K | -$18.6K | -$10.4K | -$8.1K | -$17.1K | -$8.1K | -$2.2K | -$21.00 | -$59.1K | $1.1M | -$171.7K | -$248.3K | -$248.1K | -$244.4K | -$14.4K | -$8.2K | $144.4K | $1.9K | $9.1K | ||
| Cost of Revenue * | $364.00 | $34.00 | $8.00 | $194.00 | ||||||||||||||||||||||||||||||||||||||
| General And Administrative Expense | $650.3K | $633.8K | $294.1K | $258.4K | $254.3K | $239.4K | $385.9K | $160.2K | $29.1K | $21.5K | $17.3K | $62.0K | $21.1K | $11.7K | $12.1K | $11.8K | $9.3K | $12.5K | $11.4K | $16.8K | $52.0K | $4.8K | $18.6K | $10.3K | $8.1K | $17.1K | $8.1K | $2.2K | $21.00 | $4.2K | $8.3K | $3.1K | $5.4K | $6.6K | $1.9K | $3.3K | $1.1K | $197.00 | $1.2K | |||
| Interest Expense | $22.7K | $23.6K | $27.0K | $266.2K | $22.3K | $20.2K | $19.8K | $18.5K | $17.2K | $16.6K | $15.5K | $14.5K | $16.8K | $12.7K | $11.2K | $10.8K | $9.3K | $8.0K | $6.8K | $3.1K | $1.1K | -$713.00 | -$886.00 | $1.1K | -$885.00 | -$927.00 | -$946.00 | $8.8K | ||||||||||||||
| Operating Income Loss | -$786.7K | -$633.8K | -$311.5K | -$258.4K | -$254.3K | -$239.4K | -$2.8M | -$160.2K | -$29.1K | -$21.5K | -$17.3K | -$62.0K | -$21.1K | -$11.7K | -$14.3K | -$12.0K | -$10.1K | -$12.6K | -$11.6K | -$31.1K | -$52.3K | -$4.8K | -$18.6K | -$10.3K | -$8.1K | -$17.1K | -$8.1K | -$2.2K | -$21.00 | -$16.0K | -$17.8K | |||||||||||
| Operating Expenses | $786.7K | $633.8K | $311.5K | $258.4K | $254.3K | $239.4K | $2.8M | $160.2K | $29.1K | $21.5K | $17.3K | $62.0K | $21.1K | $11.7K | $14.1K | $12.0K | $10.2K | $14.1K | $11.6K | $31.1K | $52.3K | $4.8K | $18.6K | $10.3K | $8.1K | $17.1K | $8.1K | $2.2K | $21.00 | |||||||||||||
| Nonoperating Income Expense | -$27.3K | -$29.8K | -$3.0K | -$271.2K | -$18.3K | -$24.6K | -$15.5K | -$25.4K | -$20.3K | $3.1K | -$5.9K | -$16.4K | -$10.2K | -$17.0K | -$19.4K | -$13.8K | $285.00 | -$7.9K | -$6.8K | -$1.1K | ||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic And Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Selling And Marketing Expense | $3.0K | $300.00 | $612.00 | $218.00 | $2.5K | $2.0K | $234.00 | $856.00 | $1.6K | $237.00 | $14.3K | |||||||||||||||||||||||||||||||
| Revenues | $181.00 | $120.00 | $77.00 | $1.7K | $9.2K | |||||||||||||||||||||||||||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||
| Gross Profit | -$183.00 | $86.00 | $69.00 | $1.5K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$1.1M | -$985.6K | -$835.0K | -$481.3K | -$369.7K | -$321.1K | -$321.1K | -$279.1K | -$795.4K | -$1.7M | -$749.7K | -$122.3K | $15.5K | |||
| Cash And Cash Equivalents At Carrying Value | $372.00 | $1.1K | $2.6K | $5.5K | $88.5K | $1.7K | $1.3K | $157.00 | $7.8K | $1.7K | $4.5K | |||||
| Retained Earnings Accumulated Deficit | -$5.6M | -$2.1M | -$1.9M | -$1.7M | -$1.4M | -$1.3M | -$1.2M | -$1.1M | -$105.8K | -$105.8K | -$105.8K | -$105.8K | -$105.8K | |||
| Assets | $766.7K | $6.5K | $15.3K | $10.5K | $259.2K | $105.6K | $15.1K | $3.8K | $51.0K | $11.3K | $76.8K | $6.3K | ||||
| Liabilities And Stockholders Equity | $766.7K | $6.5K | $15.3K | $10.5K | $259.2K | $105.6K | $15.1K | $3.8K | $51.0K | $65.4K | $76.8K | |||||
| Common Stock Value | $278.2K | $277.1K | $277.1K | $127.1K | $127.1K | $127.1K | $127.1K | $156.1K | $156.4K | $151.1K | $171.0K | |||||
| Liabilities Current | $3.8M | $776.8K | $660.5K | $621.3K | $518.7K | $405.3K | $336.2K | $281.7K | $199.1K | $29.1K | ||||||
| Assets Current | $2.9K | $1.1K | $7.9K | $8.1K | $252.2K | $97.6K | $1.7K | $65.4K | $1.8K | $6.3K | ||||||
| Accrued Liabilities Current | $97.3K | $125.8K | $91.7K | $71.0K | $45.4K | $14.8K | $10.0K | $10.0K | ||||||||
| Accounts Payable Current | $116.8K | $75.1K | $63.0K | $48.0K | $51.1K | $38.3K | $37.9K | $37.2K | ||||||||
| Liabilities | $4.8M | $1.1M | $1.0M | $845.5K | $740.4K | $475.3K | $336.2K | $799.2K | $1.8M | $815.1K | ||||||
| Employee Related Liabilities Current | $511.8K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | ||||||||
| Finite Lived Intangible Assets Net | $1.3K | $4.2K | $7.4K | $2.4K | $7.0K | $8.0K | $13.3K | $45.0K | ||||||||
| Notes Payable | $119.1K | $314.7K | $340.5K | $224.2K | $221.7K | $70.0K | $110.4K | $88.9K | $84.4K | $16.0K | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | $29.3K | $26.4K | $23.2K | $19.6K | $15.0K | $8.0K | $2.7K | |||||||||
| Notes Payable Current | $2.4M | $152.9K | $150.1K | $70.0K | ||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $1.4K | -$83.1K | $86.8K | $1.7K | $7.8K | -$7.6K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1K | $2.6K | $6.9K | |||||||||||||
| Cash End Of Period | $7.8K | $1.7K | $6.1K | $2.8K | ||||||||||||
| Accrued Interest | $4.4K | $3.3K | $117.00 | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $652.7K | -$763.00 | -$1.5K | -$4.3K | $1.4K | |||||||||||
| Accrued Interest Converted Into Note Payable To Shareholder | $82.2K | $66.5K | $30.3K | $42.8K | $13.8K | |||||||||||
| Cash Beginning Of Period | ||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $688.8K | $1.7M | $138.9K | $13.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q4 2009 | Q4 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$4.7M | -$4.5M | -$4.2M | -$5.1M | -$4.8M | -$4.3M | -$4.1M | -$3.9M | -$3.6M | -$1.1M | -$1.1M | -$1.0M | -$1.0M | -$937.2K | -$902.7K | -$869.0K | -$550.5K | -$516.9K | -$491.1K | -$441.0K | -$420.4K | -$402.0K | -$353.2K | -$344.5K | -$339.7K | -$317.4K | -$306.9K | -$298.8K | -$742.7K | -$693.5K | -$1.9M | -$749.7K | -$285.1K | -$280.6K | $339.1K | -$22.8K | -$13.8K | -$8.5K | -$2.5K | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $11.7K | $172.4K | $653.0K | $338.00 | $294.00 | $7.9K | $6.1K | $67.8K | $1.2K | $629.00 | $1.7K | $2.8K | $2.5K | $6.0K | $6.9K | $1.7K | $4.1K | $3.3K | $3.1K | $1.1K | $138.1K | $32.1K | $1.1K | $1.1K | $3.8K | $3.3K | $11.6K | $1.7K | $868.00 | $5.3K | $369.00 | $4.2K | $2.4K | $698.00 | $6.1K | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$9.6M | -$8.8M | -$8.1M | -$6.7M | -$6.4M | -$5.9M | -$5.3M | -$5.1M | -$2.3M | -$2.0M | -$2.0M | -$2.0M | -$1.9M | -$1.8M | -$1.8M | -$1.5M | -$1.4M | -$1.4M | -$1.3M | -$1.3M | -$1.3M | -$1.3M | -$1.2M | -$1.2M | -$1.2M | -$1.2M | -$1.1M | -$105.8K | -$105.8K | -$105.8K | -$105.8K | -$105.8K | -$105.8K | |||||||||||||||||
| Assets | $617.8K | $763.4K | $1.3M | $646.9K | $633.0K | $729.1K | $852.1K | $932.6K | $1.0M | $9.9K | $8.8K | $10.5K | $11.4K | $12.0K | $11.1K | $252.5K | $254.1K | $255.2K | $254.7K | $251.3K | $144.7K | $41.4K | $11.8K | $13.1K | $18.4K | $19.3K | $14.9K | $5.8K | $50.9K | $49.3K | $47.5K | $377.1K | ||||||||||||||||||
| Liabilities And Stockholders Equity | $617.8K | $763.4K | $1.3M | $646.9K | $633.0K | $729.1K | $852.1K | $932.6K | $1.0M | $9.9K | $8.8K | $10.5K | $11.4K | $12.0K | $11.1K | $252.5K | $254.1K | $255.2K | $254.7K | $251.3K | $144.7K | $41.4K | $11.8K | $13.1K | $18.4K | $19.3K | $16.0K | $14.9K | $5.8K | $50.9K | $49.3K | $47.5K | $377.1K | $6.3K | ||||||||||||||||
| Common Stock Value | $281.8K | $281.2K | $281.1K | $278.5K | $278.4K | $278.3K | $277.9K | $277.9K | $277.3K | $277.1K | $277.1K | $277.1K | $277.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $127.1K | $116.9K | $156.1K | $156.4K | $156.4K | $151.2K | $151.1K | $149.1K | $141.0K | ||||||||||||||||||
| Liabilities Current | $4.9M | $4.9M | $4.9M | $5.2M | $4.9M | $4.4M | $3.6M | $3.3M | $801.7K | $874.9K | $780.4K | $746.9K | $598.8K | $652.9K | $626.1K | $684.6K | $604.4K | $593.8K | $490.2K | $534.4K | $409.4K | $394.6K | $356.2K | $352.8K | $335.8K | $314.8K | $757.6K | $1.8M | $815.1K | $334.3K | $328.2K | $38.0K | ||||||||||||||||||
| Assets Current | $48.4K | $192.7K | $653.4K | $988.00 | $1.8K | $2.4K | $9.3K | $19.3K | $91.1K | $3.7K | $3.1K | $4.2K | $2.8K | $5.4K | $9.2K | $249.7K | $250.7K | $250.0K | $250.8K | $245.9K | $138.1K | $32.1K | $1.1K | $1.1K | $3.8K | $3.3K | $16.0K | $11.6K | $157.00 | $4.3K | $2.5K | $2.1K | ||||||||||||||||||
| Accrued Liabilities Current | $154.4K | $25.5K | $88.3K | $141.9K | $126.3K | $107.0K | $83.2K | $82.0K | $77.0K | $118.3K | $104.3K | $88.8K | $79.5K | $78.6K | $63.8K | $64.8K | $53.6K | $42.8K | $22.7K | $14.7K | $7.4K | $10.0K | $14.0K | $10.0K | $10.0K | $10.0K | $10.0K | |||||||||||||||||||||||
| Accounts Payable Current | $218.7K | $171.3K | $197.7K | $184.7K | $154.6K | $160.7K | $79.0K | $89.8K | $96.5K | $66.1K | $66.2K | $57.5K | $47.8K | $51.6K | $51.0K | $58.5K | $61.1K | $62.6K | $115.3K | $167.6K | $49.8K | $42.5K | $53.5K | $54.2K | $43.7K | $42.2K | $37.2K | |||||||||||||||||||||||
| Liabilities | $5.3M | $5.3M | $5.4M | $5.7M | $5.4M | $5.0M | $4.7M | $4.6M | $2.1M | $1.1M | $1.0M | $1.0M | $948.6K | $914.8K | $880.1K | $803.0K | $771.0K | $746.3K | $695.7K | $671.7K | $546.6K | $326.2K | $281.7K | $699.3K | $1.9M | |||||||||||||||||||||||||
| Employee Related Liabilities Current | $808.3K | $862.9K | $842.6K | $802.5K | $705.6K | $608.7K | $415.0K | $318.1K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | $221.2K | ||||||||||||||||||||||||
| Finite Lived Intangible Assets Net | $4.3K | $5.6K | $208.00 | $614.00 | $2.0K | $2.8K | $3.5K | $4.9K | $5.6K | $6.4K | $8.6K | $6.6K | $1.9K | $2.8K | $3.4K | $5.2K | $4.0K | $5.3K | $6.6K | $9.3K | $10.7K | $12.0K | $14.7K | $16.0K | $16.0K | |||||||||||||||||||||||||
| Notes Payable | $184.2K | $184.2K | $184.2K | $255.7K | $272.4K | $349.8K | $261.9K | $254.0K | $118.4K | $166.6K | $152.5K | $205.5K | $137.3K | $137.3K | $105.6K | $96.7K | $86.0K | $61.8K | $60.2K | $16.0K | ||||||||||||||||||||||||||||||
| Finite Lived Intangible Assets Accumulated Amortization | $4.6K | $3.3K | $30.6K | $30.4K | $30.0K | $28.6K | $27.8K | $27.1K | $25.7K | $25.0K | $24.2K | $22.0K | $20.1K | $20.1K | $18.6K | $18.6K | $16.8K | $12.0K | $10.7K | $8.0K | $4.0K | |||||||||||||||||||||||||||||
| Notes Payable Current | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.6M | $2.4M | $2.4M | $268.5K | $222.8K | $337.4K | $249.4K | $247.6K | $118.9K | $170.4K | $159.1K | $209.1K | $137.6K | $136.3K | $84.4K | $87.8K | $60.2K | ||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$948.00 | -$2.1K | $49.6K | -$598.00 | $9.9K | $4.9K | ||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.7K | $172.4K | $653.0K | $338.00 | $294.00 | $0.00 | $372.00 | $7.9K | $6.1K | $67.8K | $1.2K | $629.00 | $1.7K | |||||||||||||||||||||||||||||||||||||
| Cash End Of Period | $5.3K | $369.00 | $4.8K | $4.2K | $2.4K | $6.4K | $488.00 | $2.0K | ||||||||||||||||||||||||||||||||||||||||||
| Accrued Interest | $713.00 | $886.00 | $1.1K | $885.00 | $927.00 | $946.00 | $681.00 | $671.00 | ||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$480.6K | -$372.00 | $66.6K | -$968.00 | -$948.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Accrued Interest Converted Into Note Payable To Shareholder | $11.8K | $14.3K | $20.5K | $1.4K | $13.5K | |||||||||||||||||||||||||||||||||||||||||||||
| Cash Beginning Of Period | $369.00 | $4.8K | $7.8K | $2.4K | $6.4K | $1.7K | $2.0K | $6.1K | ||||||||||||||||||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $652.0K | $602.6K | $730.7K | $246.5K | $266.4K | $22.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow * | -$1.6M | -$457.5K | -$76.2K | -$69.9K | -$62.7K | -$291.2K | $47.1K | $36.1K | $2.6K | -$71.6K | -$54.3K | -$57.7K | |||
| Net Cash Provided By Used In Financing Activities | $2.3M | $463.1K | $76.1K | $74.3K | $64.1K | $214.1K | $133.9K | $53.9K | $2.6K | $72.8K | $46.7K | $74.5K | $81.4K | $29.0K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $78.1K | $76.4K | $36.3K | $43.4K | $5.3K | $640.00 | $387.5K | $931.6K | $591.8K | ||||||
| Increase Decrease In Prepaid Expense | $2.2K | -$2.5K | $5.3K | -$4.0K | -$1.2K | $9.1K | -$9.1K | $3.5K | -$3.4K | ||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $4.8K | $4.6K | $7.6K | -$694.00 | $361.00 | $21.00 | $441.00 | ||||||||
| Net Cash Provided By Used In Investing Activities | -$1.2K | -$6.3K | -$1.4K | -$8.6K | -$6.0K | -$16.0K | -$10.0K | ||||||||
| Proceeds From Notes Payable | $37.9K | $73.6K | $64.1K | $214.1K | $70.0K | ||||||||||
| Share Based Compensation | $132.7K | $211.7K | $45.0K | $45.0K | $45.0K | ||||||||||
| Increase Decrease In Notes Payable Related Parties | $2.00 | $63.9K | $53.9K | $2.6K | |||||||||||
| Increase Decrease In Accounts Payable | $187.9K | $159.6K | $44.0K | ||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $1.6K | $197.00 | $0.00 | ||||||||||||
| Proceeds From Related Party Debt | $10.0K | $3.5K | $200.00 | $695.00 | |||||||||||
| Increase Decrease In Notes Payable Current | $23.9K | $3.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow * | -$477.9K | -$55.3K | -$121.2K | -$35.1K | -$22.5K | -$9.1K | $17.7K | $910.00 | $17.1K | -$4.1K | -$32.2K | -$9.3K | -$20.1K | -$24.4K | -$3.0K | -$28.4K | -$9.0K | -$14.5K | -$13.6K | -$3.7K | |||||||
| Net Cash Provided By Used In Financing Activities | -$2.7K | $55.0K | $191.5K | $34.1K | $21.5K | $7.0K | $67.3K | $312.00 | $33.1K | $14.0K | $33.0K | $10.0K | $25.0K | $20.0K | -$1.1K | $30.3K | $5.0K | $20.0K | $12.0K | ||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $45.0K | -$6.1K | $8.8K | $8.5K | $4.1K | $16.3K | $49.4K | $136.9K | $164.4K | $225.0K | $222.4K | $237.2K | -$255.00 | $127.8K | -$11.8K | $5.3K | |||||||||||
| Increase Decrease In Prepaid Expense | -$19.9K | $183.00 | -$23.3K | $2.8K | -$2.1K | $9.1K | $3.5K | $82.00 | -$51.00 | $91.00 | |||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $4.2K | -$9.6K | -$196.00 | -$694.00 | -$333.00 | ||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$3.6K | -$16.0K | |||||||||||||||||||||||||
| Proceeds From Notes Payable | $34.0K | $21.5K | $7.0K | $67.3K | |||||||||||||||||||||||
| Share Based Compensation | $257.1K | $21.0K | $34.6K | ||||||||||||||||||||||||
| Increase Decrease In Notes Payable Related Parties | $2.00 | $312.00 | $33.1K | ||||||||||||||||||||||||
| Increase Decrease In Accounts Payable | -$26.4K | $63.3K | $93.8K | -$4.0K | $5.5K | -$1.6K | -$3.7K | ||||||||||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $5.7K | $3.3K | $2.9K | $2.5K | $2.0K | $1.2K | $735.00 | $313.00 | $82.00 | ||||||||||||||||||
| Proceeds From Related Party Debt | $1.6K | $1.5K | $100.00 | ||||||||||||||||||||||||
| Increase Decrease In Notes Payable Current | $9.5K | $8.0K | $25.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 278.2M | 277.1M | 277.1M | 127.1M | 127.1M | 127.1M | 127.1M | 156.1M | 156.4M | 151.1M | 149.1M | 149.1M | ||
| Common Stock Shares Authorized | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 75.0M | |
| Common Stock Shares Outstanding | 278.2M | 277.1M | 277.1M | 127.1M | 127.1M | 127.1M | 127.1M | 156.1M | 156.4M | 151.1M | 149.1M | 171.0M | 96.0K | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 183.4M | 127.1M | 127.1M | 127.1M | 137.7M | 156.1M | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 278.7M | 277.7M | 277.1M | 183.4M | ||||||||||
| Shares Issued | -1.7M | -122.3K | -22.8K | |||||||||||
| Stock Issued During Period Shares Issued For Services | 295.0K | 720.0K | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 150.3M | 143.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q2 2016 | Q1 2016 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q4 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 281.8M | 281.2M | 281.1M | 278.5M | 278.4M | 278.3M | 277.9M | 277.9M | 277.3M | 277.1M | 277.1M | 277.1M | 277.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 116.9M | 156.1M | 156.1M | 156.4M | 151.2M | 146.1M | 141.0M | 171.0M | 96.0M | ||||||||||||||
| Common Stock Shares Authorized | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | 675.0M | |||||||||||||
| Common Stock Shares Outstanding | 281.8M | 281.2M | 281.1M | 278.5M | 278.4M | 278.3M | 277.9M | 277.9M | 277.3M | 277.1M | 277.1M | 277.1M | 277.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 116.9M | 156.1M | 156.1M | 156.4M | 151.2M | 151.1M | 146.1K | 171.0K | |||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 203.7M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 127.1M | 120.7M | 156.1M | 156.1M | 156.1M | 149.9M | 141.0M | |||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 281.5M | 281.1M | 278.4M | 278.3M | 278.2M | 277.9M | 277.5M | 277.2M | 227.1M | 277.1M | 127.1M | 203.7M | 127.1M | 127.1M | 156.1M | 156.1M | 156.1M | 156.1M | 151.2M | 151.1M | 151.1M | 149.9M | 149.1M | 141.1M | |||||||||||||||||||||||
| Shares Issued | -693.5K | -1.9M | -1.4M | -1.2M | -994.0K | -749.7K | -280.6K | -277.5K | -8.5K | ||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Shares Issued For Services | 90.0K | 90.0K | 30.0K | 130.0K | 30.0K | 430.0K | 30.0K | ||||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 149.1M | 141.1M | 141.0M | 148.0M | 102.5M | 96.0M | 96.0M | 216.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $5.7K | $2.6K | $25.6K | -$4.8K | -$4.6K | -$5.9K | -$1.1K | -$220.00 | $5.9K | $3.6K | -$1.5K | $361.00 | $21.00 | $441.00 | |
| Additional Paid In Capital | $1.3M | $672.0K | $672.0K | $777.0K | $777.0K | $777.0K | $732.0K | $692.8K | $187.9K | $148.3K | $105.3K | $50.3K | $13.0K | ||
| Professional Fees | $68.3K | $38.2K | $46.8K | $42.8K | $28.6K | $15.7K | |||||||||
| Depreciation | $3.1K | $4.3K | $3.4K | $3.5K | $4.7K | $7.0K | $5.3K | $2.7K | |||||||
| Due To Related Parties Current | $131.9K | $131.7K | $131.0K | $131.0K | $131.0K | $67.1K | $13.3K | ||||||||
| Prepaid Expense Current | $2.5K | $5.3K | $1.2K | $9.1K | $3.5K | $127.00 | |||||||||
| Consulting | $302.0K | $145.0K | $106.0K | ||||||||||||
| Comprehensive Loss For Period | -$660.4K | -$211.8K | |||||||||||||
| Net Loss For Period | -$995.5K | -$659.7K | -$212.1K | ||||||||||||
| Stock Issued During Period Value Issued For Services | $132.7K | $211.7K | $5.3K | $2.0K | |||||||||||
| Net Loss Before Other Items | -$994.7K | -$655.0K | -$212.0K | -$31.5K | -$16.3K | ||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $1.0M | $1.9M | -$898.2K | -$238.5K | |||||||||||
| Foreign Currency Translation Adjustment | -$694.00 | $361.00 | |||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | |||||||||||||||
| Foreign Exchange Gain Loss | $3.6K | -$1.5K | |||||||||||||
| Contribution By Related Party | $14.3K | $13.0K | |||||||||||||
| Stock Issued During Period Shares New Issues | 2.6M | 393.3K | |||||||||||||
| Related Party Advances | $3.7K | $131.9K | |||||||||||||
| Production Costs | $9.9K | $1.1K | |||||||||||||
| Net Loss Before Other Item |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | -$539.00 | -$6.1K | -$5.0K | $4.1K | -$4.4K | $4.3K | -$6.9K | -$3.1K | $19.7K | $9.6K | -$1.9K | $6.6K | -$4.2K | -$8.2K | -$3.0K | $9.6K | $102.00 | -$86.00 | $2.0K | -$1.5K | $11.00 | -$4.00 | -$187.00 | $17.00 | $17.00 | $1.1K | -$2.7K | $1.3K | -$837.00 | |||||||||||||
| Additional Paid In Capital | $4.6M | $4.0M | $3.7M | $1.4M | $1.4M | $1.3M | $1.2M | $1.1M | $896.3K | $672.0K | $672.0K | $672.0K | $672.0K | $777.0K | $777.0K | $777.0K | $777.0K | $777.0K | $777.0K | $777.0K | $777.0K | $777.0K | $732.0K | $732.0K | $732.0K | $692.8K | $692.4K | $187.9K | $183.2K | $80.2K | $75.2K | $327.2K | ||||||||||
| Professional Fees | $13.5K | $4.0K | $5.8K | $5.4K | $5.1K | $8.6K | $2.5K | $7.6K | $22.0K | $15.9K | $1.7K | $9.0K | $16.6K | |||||||||||||||||||||||||||||
| Depreciation | $1.3K | $1.1K | $831.00 | $1.1K | $497.00 | $1.8K | $1.4K | $1.3K | ||||||||||||||||||||||||||||||||||
| Due To Related Parties Current | $131.9K | $139.3K | $131.8K | $131.4K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $121.0K | $67.6K | $67.4K | $60.9K | $52.8K | $46.4K | ||||||||||||||||||||||||
| Prepaid Expense Current | $36.8K | $20.3K | $350.00 | $650.00 | $1.5K | $2.4K | $1.4K | $13.3K | $23.3K | $2.5K | $2.5K | $2.5K | $2.8K | $3.3K | $123.4K | $65.00 | $96.00 | $1.4K | $200.00 | |||||||||||||||||||||||
| Consulting | $75.0K | $77.0K | $75.0K | $5.0K | $120.0K | |||||||||||||||||||||||||||||||||||||
| Comprehensive Loss For Period | -$248.3K | -$248.1K | -$244.4K | -$14.4K | -$8.2K | -$145.1K | -$16.0K | -$1.9K | -$9.4K | |||||||||||||||||||||||||||||||||
| Net Loss For Period | -$248.1K | -$244.4K | -$14.4K | -$8.2K | -$144.4K | -$16.0K | -$1.9K | -$9.1K | ||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $177.9K | $257.1K | $18.0K | $35.8K | $21.0K | $21.2K | $98.8K | $34.6K | ||||||||||||||||||||||||||||||||||
| Net Loss Before Other Items | -$169.9K | -$174.5K | -$247.7K | -$244.6K | -$10.7K | -$16.0K | ||||||||||||||||||||||||||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $981.2K | -$922.0K | -$2.1M | -$405.5K | -$391.1K | -$53.3K | -$26.3K | |||||||||||||||||||||||||||||||||||
| Foreign Currency Translation Adjustment | -$694.00 | -$333.00 | ||||||||||||||||||||||||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $25.0K | $20.0K | $5.0K | $5.0K | $20.0K | |||||||||||||||||||||||||||||||||||||
| Foreign Exchange Gain Loss | $1.5K | -$1.3K | $488.00 | -$2.7K | $1.3K | -$837.00 | $333.00 | |||||||||||||||||||||||||||||||||||
| Contribution By Related Party | $12.0K | |||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Shares New Issues | 485.0K | 15.0K | 50.0K | 30.0K | 153.3K | 190.0K | ||||||||||||||||||||||||||||||||||||
| Related Party Advances | $13.7K | $9.8K | $3.7K | $5.3K | $4.8K | $2.6K | $1.7K | $100.00 | ||||||||||||||||||||||||||||||||||
| Production Costs | $1.9K | $212.00 | $7.8K | $1.1K | ||||||||||||||||||||||||||||||||||||||
| Net Loss Before Other Item | -$245.9K | -$247.7K | -$10.7K | -$8.8K | -$142.9K | -$1.9K | -$9.4K |
Most recent annual filing with the SEC: June 30, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.